Elucidating the mechanisms by which PLK1 inhibition causes anemia provides valuable insights for the prevention and treatment of anemia in clinical settings, while also offering new strategies for the development of cancer therapeutics and combinatory treatments. Here, PLK1 is linked to cancer.